DOPAMINE, SEROTONIN AND SYMPTOMS OF SCHIZOPHRENIA

被引：0
|
作者：
VINAROVA, E
VINAR, O
机构：
[1] DIST HLTH CTR, DEPT PSYCHIAT, CS-29301 MLADA BOLESLAV, CZECHOSLOVAKIA
[2] STATE DRUG CONTROL INST, CS-10041 PRAGUE 10, CZECHOSLOVAKIA
[3] INST ORGAN CHEM BIOCHEM, JOINT LAB, CS-10041 PRAGUE 10, CZECHOSLOVAKIA
来源：
PSYCHOPHARMACOLOGY | 1988年 / 96卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [21] Risperidone - A novel serotonin-dopamine antagonist in the treatment of schizophrenia
    Franz, M
    Gallhofer, B
    PSYCHOPHARMAKOTHERAPIE, 1997, 4 (02): : 54 - 58
  • [22] Subchronic Effects of Phencyclidine on Dopamine and Serotonin Receptors: Implications for Schizophrenia
    Choi, Yong Kee
    Snigdha, Shikha
    Shahid, Mohammed
    Neill, Jo C.
    Tarazi, Frank I.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2009, 38 (03) : 227 - 235
  • [23] Subchronic Effects of Phencyclidine on Dopamine and Serotonin Receptors: Implications for Schizophrenia
    Yong Kee Choi
    Shikha Snigdha
    Mohammed Shahid
    Jo C. Neill
    Frank I. Tarazi
    Journal of Molecular Neuroscience, 2009, 38 : 227 - 235
  • [24] CEREBROSPINAL-FLUID CONCENTRATIONS OF DOPAMINE AND SEROTONIN METABOLITES IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER - THE SIGNIFICANCE OF POSITIVE AND NEGATIVE SYMPTOMS
    RISBY, ED
    LEWINE, RRJ
    JEWART, RD
    STIPETIC, M
    FARAJ, BA
    CAMP, VM
    CAUDLE, J
    ECCARD, M
    RISCHE, SC
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 355 - 355
  • [25] CENTRAL DOPAMINE-RECEPTORS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    MARTINOT, JL
    PAILLEREMARTINOT, ML
    LOCH, C
    AUBIN, F
    DAOCASTELLANA, MH
    DESLAURIERS, AG
    SYROTA, A
    LECRUBIER, Y
    SINGER, P
    ANNALES MEDICO-PSYCHOLOGIQUES, 1992, 150 (2-3): : 127 - 130
  • [26] Negative Symptoms and Striatal Dopamine Synthesis Capacity in Schizophrenia
    Eisenberg, Daniel
    Kohn, Philip
    Hegarty, Catherine
    Smith, Nicole
    Grogans, Shannon
    Apud, Jose
    Berman, Karen
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 498 - 499
  • [27] Serotonin transporter polymorphism and depressive-related symptoms in schizophrenia
    Golimbet, VE
    Alfimova, MV
    Shchebatykh, TV
    Abramova, LI
    Kaleda, VG
    Rogaev, EI
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 126B (01) : 1 - 7
  • [28] Positive symptoms in dopaminergic psychosis - Implications for the dopamine hypothesis of schizophrenia
    Heinz, A
    Knable, MB
    Pietzcker, A
    Schmidt, LG
    Weinberger, DR
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 151 - 151
  • [29] Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment
    Remington, Gary
    Agid, Ofer
    Foussias, George
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 589 - 607
  • [30] Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia
    S. Kasper
    J. Tauscher
    B. Küfferle
    C. Barnas
    L. Pezawas
    S. Quiner
    European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 (Suppl 4) : S83 - S89
12345